Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.

Author: AcevedoLarisa, CutlerAndrew J, DarkoDenis, DattoCatherine, MinkwitzMargaret, NordenhemArvid

Paper Details 
Original Abstract of the Article :
Bipolar disorder, a highly recurrent and chronic condition, often necessitates periods of hospitalization and requires lifelong treatment with medication. It is characterized by alternating episodes of mania and depression. Given the severity of mania, physicians must be able to control symptoms rap...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.clinthera.2011.10.002

データ提供:米国国立医学図書館(NLM)

Extended-Release Quetiapine for Treating Acute Mania

This research takes us into the turbulent world of bipolar disorder, a condition that can be as unpredictable as a desert sandstorm. The researchers here are exploring the use of extended-release quetiapine, a medication that works like a steady desert wind, helping to calm the emotional storm of acute mania. Their aim is to determine whether this medication can rapidly control the symptoms, providing a much-needed sense of stability for those struggling with manic episodes.

Extended-Release Quetiapine Shows Promise in Treating Acute Mania

The research suggests that extended-release quetiapine can be effective in managing the symptoms of acute mania, offering a beacon of hope for those battling this challenging condition. It's like finding a sturdy oasis in the middle of a raging sandstorm, providing a safe haven from the tempestuous winds of mania. The researchers highlight the need for rapid symptom control in mania, emphasizing the importance of medications like extended-release quetiapine that can bring about a sense of calm and stability.

Extended-Release Quetiapine Could Offer Better Quality of Life for Bipolar Patients

The results of this research point to the potential of extended-release quetiapine in helping patients with bipolar disorder navigate the turbulent landscape of their condition. This medication could be a valuable tool for managing manic episodes, offering a greater sense of stability and allowing individuals to better manage their lives. It's a reminder that research can provide valuable tools for those facing the challenges of mental illness, bringing much-needed relief and stability to those struggling in the desert of bipolar disorder.

Dr. Camel's Conclusion

This research on extended-release quetiapine for acute mania offers a ray of hope for patients navigating the turbulent terrain of bipolar disorder. The study highlights the potential of this medication to provide a sense of calm and stability, offering a much-needed oasis in the storm of manic episodes. It's a testament to the power of research in finding solutions for those battling mental illness, paving the way for a brighter future for those living with bipolar disorder.

Date :
  1. Date Completed 2012-03-13
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

22054797

DOI: Digital Object Identifier

10.1016/j.clinthera.2011.10.002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.